ArticleClinical drug investigation2018

Cost Effectiveness of Daclatasvir Plus Asunaprevir Therapy for Chinese Patients with Chronic Hepatitis C Virus Genotype 1b.

Yuchen Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.